Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026)
Lemaitre Vascular (LMAT) reported Income from Continuing Operations of 15679000.0 for Q1 2026, up 42.39% year-over-year from 11011000.0 in Q1 2025, and up 127.44% quarter-over-quarter from 57136000.0 in Q4 2025.
Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Income from Continuing Operations data on file, last reported at 15679000.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 15679000.0, up 42.39% year-over-year; the trailing twelve-month figure through Mar 2026 was 10316000.0 (down 123.07% YoY), and the FY2025 annual result was 14984000.0, down 134.38% from the prior year.
- Income from Continuing Operations improved to 15679000.0 in Q1 2026 per LMAT's latest filing, from 57136000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 17362000.0 in Q3 2025 and troughed at 57136000.0 in Q4 2025.
- A 5-year average of 5500294.12 and a median of 8098000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2025: Income from Continuing Operations soared 130.38% in 2023, then plunged 632.34% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 5445000.0 in 2022, then surged by 30.93% to 7129000.0 in 2023, then surged by 50.55% to 10733000.0 in 2024, then sank by 632.34% to 57136000.0 in 2025, then jumped by 127.44% to 15679000.0 in 2026.
- Business Quant data shows LMAT's Income from Continuing Operations at 15679000.0 in Q1 2026, 57136000.0 in Q4 2025, and 17362000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 15.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.68 Mn |
| Dec 31, 2025 | -57.14 Mn |
| Sep 30, 2025 | 17.36 Mn |
| Jun 30, 2025 | 13.78 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | 10.73 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Jun 30, 2024 | 11.83 Mn |
| Mar 31, 2024 | 9.89 Mn |
| Dec 31, 2023 | 7.13 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 8.10 Mn |
| Mar 31, 2023 | 6.04 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 6.04 Mn |
| Dec 31, 2021 | 6.25 Mn |
| Sep 30, 2021 | 6.50 Mn |
| Jun 30, 2021 | 8.30 Mn |